Clinical Trials List
2012-12-01 - 2014-12-31
Phase III
Terminated10
ICD-10E11.21
Type 2 diabetes mellitus with diabetic nephropathy
ICD-10E11.22
Type 2 diabetes mellitus with diabetic chronic kidney disease
ICD-10E11.29
Type 2 diabetes mellitus with other diabetic kidney complication
ICD-10E13.21
Other specified diabetes mellitus with diabetic nephropathy
ICD-10E13.22
Other specified diabetes mellitus with diabetic chronic kidney disease
ICD-10E13.29
Other specified diabetes mellitus with other diabetic kidney complication
ICD-9250.40
Diabetes with renal manifestations, Type II [non-insulin dependent type][NIDDM type][adult-onset type] or unspecified type ,not stated as uncontrolled
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 洪士元 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Chin-Sung Kuo Division of Endocrinology
- Ching Fai Kwok Division of Endocrinology
- Chia-Chang Huang Division of Endocrinology
- Liang-Yu Lin Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
404 participants
